Stanford researchers have developed a patented microscopy method which can provide chemical identification of molecular structures with radiation spectroscopy at nanometer or near-atomic scales, which is one of the most challenging problems in microscopy.
Dr. Curt Scharfe and colleagues have developed RUSPseq, a method for next generation molecular testing originally conceived to diagnose metabolic disorders in newborns.
Stanford researchers have developed a framework describing an end-to-end approach that infers experimental properties directly from nucleic acid sequence, using a principled statistical mechanical representation of the structure ensemble.
Multiplexed analysis of biological components is critical for classifying molecular subtypes of heterogeneous tumors to provide patient-specific therapies.
Stanford researchers in the Kanan group have developed a electrolysis cell for generating and extracting liquid and gas product streams from CO and CO2.
Researchers at Stanford University have discovered an invention to reverse tumor-induced CAR-T cell and CD8+ T cell exhaustion with administration of annexin V.
Stanford researchers have developed a multi-omics method for predicting the strength and durability of immune responses to vaccines shortly after vaccination. The COVID-19 pandemic was a grave demonstration of the threat pandemics pose to global public health.
Stanford engineers have developed a wearable, real-time activity monitor that estimates metabolic energy expenditure with substantially lower error than current methods such as smartwatches.
Stanford researchers in The Tang Group have developed a reproducible, high throughput device that dices tissue into uniformly sized sub-millimeter sample fragments.
Stanford inventors have discovered that applying a hydrogel containing an inhibitor of mechanotransduction pathways on top of a skin graft reduces scarring and promotes healing after repair of traumatic injuries like severe burn wounds.
A common hurdle for many drug delivery applications is getting the desired compounds to the targeted cells or receptors. Additional barriers of achieving the therapeutic drug concentration and necessary drug diffusion are also present even after successful targeted delivery.
Stanford scientists have invented a method that can determine the gestational age of a fetus by testing the mother's urine using metabolomics profiling and machine learning.